A source of information
that few know exists
Members get the change to define and prioritize the most pressing challenges we want to tackle, as well as influence how we tackle them. Among the critical challenges your peers want to address include:
Transitioning from animal to human models in the progression of TPD drugs through the clinic
Knowing what new class of targets have the greatest potential for TPD drug development
The development of molecular glues compared to PROTACs
Methodologies to find E3 ligases
Optimizing In Vivo profiling to predict what will happen in humans
Challenges around the primary modality of degradation
The scientific parameters around how degraders work
Innovation doesn't happen in isolation
Searchlight makes meaningful progress
“Success stories get presented at conferences but comparing notes and experiences around what didn’t work and getting ideas & input around specific questions is where the real value lies. This network offers a rare and vital chance for us to get exactly that insight.”
“This network is worthwhile because it facilitates community connection and scientific exchange to find answers to the toughest questions together – benefiting our community and our patients.”
“Usually, we hear about the 1% of things that worked, this network presents the golden opportunity to hear about the 99% of things that didn’t.”
Membership brochure
For more information on what’s included as part of the Targeted Protein Degradation: Searchlight membership, please download the membership brochure.
Here’s what you’ll learn more about:
- The unique mission and purpose of the network
- What membership includes
- How the quarterly cornerstone meetings work
- How bespoke value delivery works
- How we deliver demonstrable value to you
- Annual member investment